Clinical Trial Update: Adjunctive Withania Somnifera (Ashwagandha) for Persistent Symptoms in People With Schizophrenia [Phase 2, Phase 3]

View source ↗

Summary

This update reports results from a Phase 2/3 trial evaluating adjunctive Ashwagandha (Withania somnifera) for persistent symptoms in schizophrenia, which was te…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• Ashwagandha (Withania somnifera)

Snippet

Sponsor: Chengappa, K.N. Roy, MD | Conditions: Schizophrenia | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2024-10-08